Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Depressive Disorder and CYP2B6[original query] |
|---|
| Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients. International journal of clinical pharmacy 2016 Jan . Yuce-Artun Nazan, Baskak Bora, Ozel-Kizil Erguvan Tugba, Ozdemir Hatice, Uckun Zuhal, Devrimci-Ozguven Halise, Suzen Halit Sin |
| Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools. The pharmacogenomics journal 2018 5 18 (5): 613-622. Bousman Chad A, Dunlop Boadie |
| Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer status. The pharmacogenomics journal 2020 Jun . Gaebler Arnim Johannes, Schneider Katharina Luise, Stingl Julia Carolin, Paulzen Micha |
| Pharmacogenomic Characterization of Childbearing-Aged Individuals With Mood Disorders in a Tertiary Care Perinatal Mental Health Clinic. The Journal of clinical psychiatry 2024 6 85 (2): . Jessica L W Mayer, Hannah K Betcher, Laura J Rasmussen-Torvik, Amy Yang, Alfred L George, Tatiana Abramova, Catherine S Stika, Katherine L Wisner, Crystal T Clark, Jacqueline Goll |
- Page last reviewed:Feb 1, 2024
- Content source: